{"symbol": "NTLA", "companyName": "Intellia Therapeutics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.intelliatx.com", "description": "Intellia Therapeutics Inc is a gene editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as the CRISPR/Cas9 system.", "CEO": "John M. Leonard", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}